Literature DB >> 23884586

Entry of influenza virus.

Xiangjie Sun1, Gary R Whittaker.   

Abstract

As a major pathogen of human and certain animal species, influenza virus causes wide spread and potentially devastating disease. To initiate infection, the virus first binds to cellular receptors comprising either -(2,3 ) or -(2,6) linked sialic acid. Recent advances in our understanding of the influenza virus receptor and viral host species involved have shed light on the molecular mechanism of how influenza virus transmits across species and adapts to a new host. Following receptor binding, influenza viruses are internalized through multiple endocytic pathways, including both clathrin- and non-clathrin-dependent routes, which have recently been visualized at single viral particle level. The viral envelope then fuses with the endosomal membrane in a low pH-dependent manner and the viral genome is released into the cytosol, followed by further transport to the nucleus where genome replication occurs.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23884586     DOI: 10.1007/978-1-4614-7651-1_4

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  22 in total

1.  DESC1 and MSPL activate influenza A viruses and emerging coronaviruses for host cell entry.

Authors:  Pawel Zmora; Paulina Blazejewska; Anna-Sophie Moldenhauer; Kathrin Welsch; Inga Nehlmeier; Qingyu Wu; Heike Schneider; Stefan Pöhlmann; Stephanie Bertram
Journal:  J Virol       Date:  2014-08-13       Impact factor: 5.103

2.  Neutralization of Virus Infectivity by Antibodies: Old Problems in New Perspectives.

Authors:  P J Klasse
Journal:  Adv Biol       Date:  2014-09-09

3.  A Functional Role of Fibroblast Growth Factor Receptor 1 (FGFR1) in the Suppression of Influenza A Virus Replication.

Authors:  Xin Liu; Chengcai Lai; Keyu Wang; Li Xing; Penghui Yang; Qing Duan; Xiliang Wang
Journal:  PLoS One       Date:  2015-04-24       Impact factor: 3.240

4.  Influenza A virus encoding secreted Gaussia luciferase as useful tool to analyze viral replication and its inhibition by antiviral compounds and cellular proteins.

Authors:  Nadine Eckert; Florian Wrensch; Sabine Gärtner; Navaneethan Palanisamy; Ulrike Goedecke; Nils Jäger; Stefan Pöhlmann; Michael Winkler
Journal:  PLoS One       Date:  2014-05-19       Impact factor: 3.240

Review 5.  Compounds with anti-influenza activity: present and future of strategies for the optimal treatment and management of influenza. Part I: Influenza life-cycle and currently available drugs.

Authors:  R Gasparini; D Amicizia; P L Lai; N L Bragazzi; D Panatto
Journal:  J Prev Med Hyg       Date:  2014-09

6.  Influenza virus exploits tunneling nanotubes for cell-to-cell spread.

Authors:  Amrita Kumar; Jin Hyang Kim; Priya Ranjan; Maureen G Metcalfe; Weiping Cao; Margarita Mishina; Shivaprakash Gangappa; Zhu Guo; Edward S Boyden; Sherif Zaki; Ian York; Adolfo García-Sastre; Michael Shaw; Suryaprakash Sambhara
Journal:  Sci Rep       Date:  2017-01-06       Impact factor: 4.379

7.  Cleavage of hemagglutinin-bearing lentiviral pseudotypes and their use in the study of influenza virus persistence.

Authors:  Olivier Sawoo; Amélie Dublineau; Christophe Batéjat; Paul Zhou; Jean-Claude Manuguerra; India Leclercq
Journal:  PLoS One       Date:  2014-08-28       Impact factor: 3.240

8.  Establishment of MDCK Stable Cell Lines Expressing TMPRSS2 and MSPL and Their Applications in Propagating Influenza Vaccine Viruses in Absence of Exogenous Trypsin.

Authors:  Zhiyuan Wen; Chao Wu; Weiye Chen; Xianying Zeng; Jianzhong Shi; Jinying Ge; Hualan Chen; Zhigao Bu
Journal:  Biotechnol Res Int       Date:  2015-03-30

9.  Host virus and pneumococcus-specific immune responses in high-count monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia: implications for disease progression.

Authors:  Ignacio Criado; Santiago Muñoz-Criado; Arancha Rodríguez-Caballero; Wendy G Nieto; Alfonso Romero; Paulino Fernández-Navarro; Miguel Alcoceba; Teresa Contreras; Marcos González; Alberto Orfao; Julia Almeida
Journal:  Haematologica       Date:  2017-04-06       Impact factor: 9.941

Review 10.  Host Immune Response to Influenza A Virus Infection.

Authors:  Xiaoyong Chen; Shasha Liu; Mohsan Ullah Goraya; Mohamed Maarouf; Shile Huang; Ji-Long Chen
Journal:  Front Immunol       Date:  2018-03-05       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.